Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Approaches to in vitro tissue regeneration with application for human disease modeling and drug development

Ebrahimkhani MR., Young CL., Lauffenburger DA., Griffith LG., Borenstein JT.

Narrative Review, published in Drug Discov Today (2014) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Drug Discov Today (2014)
Reported sample size
—
Source database
Europe PMC
PMID
24793141
PMCID
PMC4104173
DOI
10.1016/j.drudis.2014.04.017
Citations
31

Abstract (original English)

Reliable in vitro human disease models that capture the complexity of in vivo tissue behaviors are crucial to gain mechanistic insights into human disease and enable the development of treatments that are effective across broad patient populations. The integration of stem cell technologies, tissue engineering, emerging biomaterials strategies and microfabrication processes, as well as computational and systems biology approaches, is enabling new tools to generate reliable in vitro systems to study the molecular basis of human disease and facilitate drug development. In this review, we discuss these recently developed tools and emphasize opportunities and challenges involved in combining these technologies toward regenerative science.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansDisease Models, AnimalGuided Tissue RegenerationTissue EngineeringRegenerationDrug Discovery

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.